Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region). (Q39509015)

12 September 2017

title

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region). (English)

1 reference

12 September 2017

1 reference

Schröder FH

1 reference

12 September 2017

Kranse R

1 reference

12 September 2017

Beemsterboer P

1 reference

12 September 2017

Rietbergen J

1 reference

12 September 2017

Habbema D

1 reference

12 September 2017

Hugosson J

1 reference

12 September 2017

publication date

1 June 1999

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

316-322

1 reference

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

A retrospective cohort study of vasectomy and prostate cancer in US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990601%2939%3A4%3C316%3A%3AAID-PROS14%3E3.0.CO%3B2-O

10.1002/(SICI)1097-0045(19990601)39:4<316::AID-PROS14>3.0.CO;2-O

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference